The Short Answer
Yes, you can often get life insurance after a cancer diagnosis. Whether you can qualify for fully underwritten coverage at standard or near-standard rates, or whether you are looking at rated coverage, a waiting period, or guaranteed issue as a last resort, depends on several specific factors: the type of cancer, the stage at diagnosis, how treatment went, how long ago treatment ended, and whether you are currently in remission. No two cancer histories are the same from an underwriter’s perspective, and neither are the outcomes.
If you are currently in active treatment or were recently diagnosed, traditional underwritten coverage is almost certainly not available yet. The path forward depends on where you are in the treatment and recovery process. Understanding what underwriters look for allows you to time your application strategically and set realistic expectations.
How Insurers Evaluate Cancer History
Life insurance underwriters reviewing cancer history are looking for a set of specific data points. They want to know the type and location of cancer, the stage at diagnosis (I through IV), the treatment protocol (surgery, radiation, chemotherapy, immunotherapy, or some combination), whether treatment is complete, the date of remission, whether there has been any recurrence, and current clinical status.
These details come from your attending physician’s statement, medical records, and sometimes pathology reports. The underwriter is not making a judgment call based on intuition — they are applying actuarial tables that reflect mortality data for specific cancer types and stages, adjusted for time since remission. The longer you have been in remission, the better your mortality data looks, and the better your chances of approval at a reasonable rate.
Most insurers also look at family history of the same cancer, current lifestyle factors (smoking history in particular), overall health status, and any residual effects of treatment that might affect long-term health. Peripheral neuropathy from chemotherapy, cardiovascular effects from radiation, or secondary conditions that developed during or after treatment are all relevant.
Cancers That Are Treated More Favorably
Some cancers, when caught early and treated successfully, have excellent long-term prognosis and are treated relatively favorably by underwriters after an appropriate waiting period.
Basal cell skin carcinoma is typically the most straightforward. Most insurers treat it as a non-event once treatment is complete. Squamous cell carcinoma of the skin is also generally manageable, though more invasive cases get more scrutiny. These are by far the most common cancers in the U.S. and the least likely to significantly affect life insurance premiums if treated and resolved.
Thyroid cancer, particularly papillary thyroid cancer caught at an early stage, has a very high survival rate and is typically treatable with surgery and sometimes radioactive iodine. After a few years in remission, many applicants with a history of early-stage thyroid cancer can qualify for standard or near-standard rates.
Early-stage breast cancer — Stage I, particularly hormone-receptor positive — is another category where underwriting has become more favorable as survival data has improved. A 45-year-old woman with a history of Stage I breast cancer treated with surgery and radiation, now five years in remission, can often qualify for coverage, though with a rating that increases the premium over the standard rate. The rating reduces over time as remission extends.
Prostate cancer is complicated because it varies enormously by grade and stage. A low-risk Gleason score 6 prostate cancer treated with surgery or radiation in a 60-year-old may be viewed quite differently from a higher-grade cancer. Some insurers have developed prostate-specific underwriting guidelines that are reasonably accommodating for low-risk cases after several years of remission.
Cervical cancer at early stages (Stage I, IA) treated successfully has generally positive underwriting outcomes after remission. In-situ cervical cancer (CIN III/carcinoma in situ) is often treated as a non-event once resolved.
Melanoma is highly stage-dependent. Stage I melanoma, particularly thin lesions, can sometimes be insured after a waiting period. Stage III and IV melanoma is a very different story and may result in declinature or only guaranteed issue options being available.
Cancers That Create More Difficulty
Some cancers are viewed much more conservatively by underwriters regardless of treatment outcome, at least within the first several years after diagnosis.
Lung cancer, particularly non-small cell lung cancer at Stage II or above, typically results in declinature for fully underwritten coverage for at least 5 to 10 years post-remission, and many cases are declined indefinitely through traditional underwriting. The recurrence rates and mortality data are less favorable than other cancer types, and underwriters price that in.
Pancreatic cancer, glioblastoma, and most Stage IV cancers across any type are generally uninsurable through traditional underwriting. Survival statistics for these cancers, even with treatment, do not support standard underwriting. Guaranteed issue products, which do not require medical underwriting, are typically the only option.
Blood cancers — leukemia, lymphoma, multiple myeloma — vary significantly. Some forms of Hodgkin lymphoma have excellent long-term outcomes and can be insurable after an extended remission period. Non-Hodgkin lymphoma and leukemia are more variable. Underwriters look closely at the specific type, treatment, and whether bone marrow or stem cell transplant was part of the protocol.
Breast cancer at Stage II or above, particularly triple-negative breast cancer (which lacks hormone receptors and tends to be more aggressive), faces more conservative underwriting. A longer remission period — often 5 to 10 years — is required before most traditional insurers will consider an application, and even then the rating may be significant.
Colon cancer at Stage III requires several years of remission and documentation of clear follow-up colonoscopies. Stage IV colon cancer is generally not insurable through traditional underwriting during any practical remission window.
Timing: Why Waiting Matters
Timing your application correctly is one of the most important strategic decisions when you have a cancer history. Applying too soon — before you have established a meaningful remission period — is likely to result in a decline or an astronomical rating. A decline can affect future applications because some insurers ask whether you have ever been declined for life insurance.
As a general rule, most underwriters want to see at minimum two years of remission for lower-risk cancers before considering an application. For moderate-risk cancers, the wait is often five years. For higher-risk cancers, it may be ten years or more, and in some cases traditional underwriting is simply not available regardless of time elapsed.
During the waiting period, if you have group life insurance through an employer, preserve it. Do not voluntarily cancel employer-provided coverage while you are medically uninsurable. If you leave your employer, look into conversion rights — most group plans allow you to convert to an individual policy within a certain window without medical underwriting, and that conversion right is valuable if you cannot otherwise qualify.
If you are approaching the end of active treatment and are expecting remission, start learning about the timeline now. Talk to an independent broker who specializes in impaired-risk life insurance — not every broker has experience navigating cancer underwriting, and working with someone who does can save you from premature applications and declines.
What the Underwriting Process Looks Like
The application process for someone with a cancer history is more involved than standard underwriting. You will complete the standard application questions disclosing your diagnosis, treatment, and current status. The insurer will then order medical records from your oncologist and primary care physician. Depending on the cancer type and elapsed time, they may also require a current physician’s statement or lab work.
The underwriter reviews all of this and classifies the application: standard (preferred/preferred plus is unlikely for most cancer histories), rated (a table rating that increases your premium by a percentage above standard), or declined. Table ratings are expressed in a system where each table level typically adds 25 percent to the standard premium. A table 4 rating means roughly 100 percent above standard — you pay double the standard rate. Table ratings often decrease over time as remission extends, which is why many people apply multiple times at different points in their remission history.
Different insurers apply their cancer guidelines differently. One insurer may decline a Stage II breast cancer history at three years of remission while another offers a table 4 rating. This is why working with an independent broker who can shop across multiple carriers matters significantly for cancer cases. The difference in outcomes between carriers can be substantial.
Guaranteed Issue Life Insurance
Guaranteed issue life insurance accepts all applicants within an age range — typically 50 to 85 — with no medical questions and no underwriting. You cannot be declined. The tradeoffs are real: face amounts are limited (typically $5,000 to $25,000, sometimes up to $50,000), premiums are high relative to coverage, and most policies have a graded death benefit for the first two or three years — meaning if you die from natural causes during that period, your heirs receive only the premiums paid plus interest, not the full face amount.
For someone with a cancer diagnosis who cannot qualify for any traditionally underwritten coverage, guaranteed issue is a legitimate option for covering final expenses, small debts, or leaving something to a family member. It is not a solution for income replacement or estate planning at meaningful amounts. It is a last resort with limited capacity, not a substitute for fully underwritten coverage.
Accidental death policies are sometimes suggested in this context as well, but those only pay if death results from an accident — not illness. For someone with a cancer history, accidental death coverage does not address the actual mortality risk and should not be confused with life insurance for this purpose.
Practical Steps If You Have a Cancer History
First, gather your medical records and treatment summary. Know your diagnosis, stage, treatment protocol, end-of-treatment date, and follow-up schedule. Underwriters will request this anyway, and knowing what is in your file helps you communicate accurately and avoids inconsistencies in the application.
Second, work with an independent broker who has experience with impaired risk or high-risk life insurance cases. These brokers know which carriers are more favorable for specific cancer types and can pre-screen your situation before submitting a formal application, reducing the risk of a formal decline on your record.
Third, consider the timing carefully. If you are close to a milestone remission date that typically improves underwriting outcomes — for example, approaching the five-year mark — it may be worth waiting a few months if you are not in an urgent situation. A policy at a table 2 rating is meaningfully less expensive than the same policy at a table 6 rating.
Fourth, preserve all existing coverage while you are navigating this. Group employer coverage, conversion rights, any existing individual policies — do not let anything lapse during the period when you may not be able to qualify for new coverage.
Fifth, be honest on your application. Misrepresentation on a life insurance application — including failing to disclose a cancer history — is grounds for rescission of the policy and denial of a claim. The two-year contestability period means the insurer reviews the application when a claim is filed within the first two years. A misrepresentation discovered at claim time is the worst possible outcome: your family gets nothing.